Company Data
BioAtla Inc.
Ticker
BCAB
Current Price
$0.42 -6%
Market Cap
$24.7M
Price Target
Refer to Report
Volume
530.8K
52wk Range
$0.24 - $2.525
Overview
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.